missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CA125 Monoclonal Antibody (Ov185:1), Invitrogen™
Beschreibung
MA5-11579 targets CA-125 in IHC (P) applications and shows reactivity with Human samples. The MA5-11579 immunogen is partially purified mucin fraction from a pool of cancer tissue from patients with epithelial ovarian cancer.
CA 125 determinant is present on a high molecular weight, mucin like glycoprotein of high molecular weight. CA 125 has been found on frozen sections of amnion and derivatives of coelomic and mullerian epithelium, including pleura, pericardium and peritoneum. In adult tissues, epithelial cells of fallopian tube, endometrium and endocervix; pancreas, colon, gall bladder, stomach, kidney, apocrine sweat gland and mammary gland. It is also found in mesothelial cell lining of pleura, pericardium and peritoneum. It is found in ovarian tumors of serous, endometrioid or clear cell types and adenocarcinomas of mullerian type.
Spezifikation
Spezifikation
| Antígeno | CA125 |
| Aplicaciones | Immunocytochemistry, Immunohistochemistry (Paraffin) |
| Clasificación | Monoclonal |
| Clon | Ov185:1 |
| Concentración | Conc. Not Determined |
| Conjugado | Unconjugated |
| Formulación | tissue culture supernatant with 0.09% sodium azide |
| génica | MUC16 |
| N.º de referencia del gen | Q8WXI7 |
| Alias de gen | 1110008I14Rik; Ca125; CA-125; CA125 ovarian cancer antigen; ca-ovarian; FLJ14303; Gm1480; MUC16; MUC-16; mucin 16; mucin 16, cell surface associated; mucin-16; Ovarian cancer-related tumor marker CA125; ovarian carcinoma antigen CA125; RGD1308422 |
| Mehr anzeigen |
Name des Produkts
Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.
Haben Sie Verbesserungsvorschläge?